Can platelet-rich plasma therapy save patients with ulnar collateral ligament tears from surgery?

被引:12
作者
Kato, Yuki [1 ]
Yamada, Shin [1 ]
Chavez, Jover [2 ]
机构
[1] Kameda Med Ctr, Dept Sports Med, 929 Higashi Cho, Kamogawa City, Chiba 2968602, Japan
[2] Global Care Med Ctr Canlubang, Laguna, Philippines
来源
REGENERATIVE THERAPY | 2019年 / 10卷
关键词
Platelet-rich plasma; Regenerative therapy; Ulnar collateral ligament; AUTOLOGOUS CONDITIONED PLASMA; GROWTH-FACTOR; INJECTIONS;
D O I
10.1016/j.reth.2019.02.004
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Introduction: Platelet-rich plasma (PRP) has been shown to be effective in treating partial tears of the ulnar collateral ligament (UCL) of the elbow in overhead throwing athletes, but it is still unknown whether it has a role in complete tears. The aim of this study was to assess the effectiveness of PRP in treating complete as well as partial UCL tears. We hypothesized that trephination of the injured UCL followed by injection with PRP can promote healing of both partial and complete tears. Methods: Thirty-four baseball players with partial or complete UCL tears confirmed by magnetic resonance imaging (MRI) were included in the study. They were all recalcitrant to more than two months of rest and physical therapy. Under ultrasound guidance, trephination of the UCL was performed using an 18-gauge needle, followed by PRP injection. Visual analog scale (VAS) scores, Disabilities of the Arm, Shoulder, and Hand (DASH) sports module scores, and sonographic ulnohumeral joint space measurements with valgus stress were all obtained prior to the procedure and six months after. Results: Twenty-six of 30 athletes were able to return to sport with pre-injury level of play within six months after the procedure, at an average time of 12.4 weeks (range: 10-18). Four subjects needed surgical treatment for persistent UCL insufficiency. The average follow-up was 54.2 weeks (range: 26-148). The average VAS and DASH scores improved from 53.5 to 17.2 (p < 0.0001) and from 81.7 to 24.2 (p < 0.0001), respectively. The average ulnohumeral joint space opening with valgus stress decreased from 3.81 mm to 3.45 mm (p = 0.018). Subgroup analysis by injury location revealed that the average VAS score improved from 48.2 to 8.6 (p < 0.0001) and from 64.0 to 34.5 (p = 0.0023) in proximal and distal tears, respectively. The average DASH score improved from 83.8 to 17.8 (p = 0.0001) and from 77.5 to 36.7 (p < 0.0001) in proximal and distal tears, respectively. The average ulnohumeral joint space opening with valgus stress decreased from 3.64 to 3.21 mm (p = 0.003) and from 4.14 to 3.92 mm (p = 0.0023) in proximal and distal tears, respectively. There was one case with a proximal tear that needed surgical management for failure of treatment, while there were three cases needing surgery in those with distal tears. Conclusion: Ultrasound-guided PRP injection following trephination can be an effective treatment option for both partial and complete UCL tears of the elbow, especially proximal tears. The use of this technique for complete UCL tears may allow more athletes to avoid surgery and enable them to return to play faster. (C) 2019, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
引用
收藏
页码:123 / 126
页数:4
相关论文
共 50 条
  • [31] Effect of alendronate and platelet-rich plasma in tendon-bones integration in sheep anterior cruciate ligament surgery
    Sibarani, Tangkas
    Purwanto, Bambang
    Mudigdo, Ambar
    Wasita, Brian
    JOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH, 2024, 12 (03): : 526 - 538
  • [32] Platelet-Rich Plasma Therapy and Antithrombotic Drugs
    Anitua, Eduardo
    Prado, Roberto
    Orive, Gorka
    PAIN PHYSICIAN, 2017, 20 (02) : E335 - E336
  • [33] Has platelet-rich plasma any role in partial tears of the anterior cruciate ligament? Prospective comparative study
    Zicaro, Juan Pablo
    Garcia-Mansilla, Ignacio
    Zuain, Andres
    Yacuzzi, Carlos
    Costa-Paz, Matias
    WORLD JOURNAL OF ORTHOPEDICS, 2021, 12 (06): : 423 - 432
  • [34] Update on Platelet-Rich Plasma and Platelet-Rich Fibrin for Dermatologic Surgery: Addressing Knowns and Unknowns
    Proffer, Sydney L.
    Wyles, Saranya P.
    Hausauer, Amelia K.
    DERMATOLOGIC SURGERY, 2024, 50 (11S) : S149 - S159
  • [35] Exploring Platelet-Rich Plasma Therapy for Knee Osteoarthritis: An In-Depth Analysis
    Blaga, Florin Nicolae
    Nutiu, Alexandru Stefan
    Lupsa, Alex Octavian
    Ghiurau, Nicu Adrian
    Vlad, Silviu Valentin
    Ghitea, Timea Claudia
    JOURNAL OF FUNCTIONAL BIOMATERIALS, 2024, 15 (08)
  • [36] Platelet-rich plasma therapy in dogs with bilateral hip osteoarthritis
    Alves, J. C.
    Santos, A.
    Jorge, P.
    BMC VETERINARY RESEARCH, 2021, 17 (01)
  • [37] Advances and prospects of platelet-rich plasma therapy in veterinary ophthalmology
    Sharun, Khan
    Chandran, Deepak
    Manjusha, K. M.
    Mankuzhy, Pratheesh D.
    Kumar, Rohit
    Pawde, Abhijit M.
    Dhama, Kuldeep
    El-Husseiny, Hussein M.
    Amarpal
    VETERINARY RESEARCH COMMUNICATIONS, 2023, 47 (03) : 1031 - 1045
  • [38] The History and Current Status of Platelet-Rich Plasma Therapy in Dermatology
    Rodriguez, Melanie
    Mayrovitz, Harvey N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [39] Platelet-rich plasma therapy in dogs with bilateral hip osteoarthritis
    J. C. Alves
    A. Santos
    P. Jorge
    BMC Veterinary Research, 17
  • [40] Platelet-rich plasma is a promising therapy for melasma
    Tuknayat, Ankita
    Bhalla, Mala
    Thami, Gurvinder Pal
    JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (08) : 2431 - 2436